Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $222.37B.
ENTERPRISE VALUE (EV)
$222.37B
Pfizer Inc.
Market Cap
$158.39B
Enterprise Value (EV)
$222.37B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Pfizer Inc. (PFE) | $158.39B | $222.37B |
| Danaher Corporation (DHR)vs › | $144.25B | $168.19B |
| Gilead Sciences, Inc. (GILD)vs › | $182.06B | $210.54B |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $134.24B | $130.07B |
| Abbott Laboratories (ABT)vs › | $182.59B | $214.94B |
| Bristol-Myers Squibb Company (BMY)vs › | $132.14B | $170.89B |
| Intuitive Surgical, Inc. (ISRG)vs › | $123.70B | $124.32B |
| CVS Health Corp. (CVS)vs › | $122.58B | $188.41B |
| Medtronic plc (MDT)vs › | $118.26B | $116.92B |
| Novo Nordisk A/S (NVO)vs › | $200.54B | $216.42B |
Market Cap
$158.39B
Total Debt
$65.13B
Cash
$1.14B
Enterprise Value
$222.37B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
